Similar articles

• How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

  Ragnhammar P, Blomgren H. Ragnhammar P, et al. Med Oncol. 1995 Sep;12(3):187-201. doi: 10.1007/BF01571196. Med Oncol. 1995. PMID: 8852401 Review. No abstract available.
• Metastatic colorectal cancer: advances in biochemical modulation and new drug development.

  Meropol NJ, Creaven PJ, Petrelli NJ. Meropol NJ, et al. Semin Oncol. 1995 Oct;22(5):509-24. Semin Oncol. 1995. PMID: 7570061 Review. No abstract available.
• Sparfosate. A novel biomodulator of 5-fluorouracil.

  Koshland P, Maa L, Ignoffo R. Koshland P, et al. Cancer Pract. 1999 Jul-Aug;7(4):212-6. doi: 10.1046/j.1523-5394.1999.74011.x. Cancer Pract. 1999. PMID: 10687588 Review. No abstract available.
• Biochemical modulation of 5-fluorouracil by PALA.

  O'Dwyer PJ. O'Dwyer PJ. Cancer Invest. 1990;8(2):261-2. doi: 10.3109/07357909009017577. Cancer Invest. 1990. PMID: 2400945 No abstract available.
• Chemotherapy of advanced cancer of the colon and rectum.

  Bruckner HW, Motwani BT. Bruckner HW, et al. Semin Oncol. 1991 Oct;18(5):443-61. Semin Oncol. 1991. PMID: 1925632 Review. No abstract available.